Akcea Therapeutics, Inc. Operating Cash Flow
Akcea Therapeutics, Inc. reported Operating Cash Flow of -$77.53 million for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-05.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2020-08-05
- Akcea Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2020-06-30 was -$33.42M.
- Akcea Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2020-03-31 was -$44.10M, a 156.12% decline year-over-year.
- Akcea Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2019-12-31 was $208.73M.
- Akcea Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2019-09-30 was -$34.73M.
- Akcea Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2019 was $223.82M.
- Akcea Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2018 was -$202.89M.
- Akcea Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2017 was -$36.19M.
- Akcea Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2016 was -$55.36M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2020-06-30 | -$33.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$77.53M 10-Q · filed 2020-08-05 | $131.21M derived: sum of 3 quarters · filed 2020-08-05 | $96.47M derived: sum of 4 quarters · filed 2020-08-05 |
| 2020-03-31 | -$44.10M 10-Q · filed 2020-05-06 | $164.63M derived: sum of 2 quarters · filed 2020-05-06 | $129.90M derived: sum of 3 quarters · filed 2020-05-06 | $101.13M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-12-31 | $208.73M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $174.00M derived: sum of 2 quarters · filed 2020-03-02 | $145.23M derived: sum of 3 quarters · filed 2020-08-05 | $223.82M 10-K · filed 2020-03-02 |
| 2019-09-30 | -$34.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$63.50M derived: sum of 2 quarters · filed 2020-08-05 | $15.09M 10-Q · filed 2019-11-06 | -$53.63M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-06-30 | -$28.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $49.82M 10-Q · filed 2020-08-05 | -$18.90M derived: sum of 3 quarters · filed 2020-08-05 | -$81.75M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $78.59M 10-Q · filed 2020-05-06 | $9.87M derived: sum of 2 quarters · filed 2020-05-06 | -$52.98M derived: sum of 3 quarters · filed 2020-05-06 | -$107.53M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | -$68.72M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$131.58M derived: sum of 2 quarters · filed 2020-03-02 | -$186.13M derived: sum of 3 quarters · filed 2020-03-02 | -$202.89M 10-K · filed 2020-03-02 |
| 2018-09-30 | -$62.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$117.40M derived: sum of 2 quarters · filed 2019-11-06 | -$134.17M 10-Q · filed 2019-11-06 | -$158.68M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | -$54.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$71.31M 10-Q · filed 2019-08-07 | -$95.83M derived: sum of 3 quarters · filed 2020-03-02 | -$113.51M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$16.76M 10-Q · filed 2019-05-09 | -$41.28M derived: sum of 2 quarters · filed 2020-03-02 | -$58.96M derived: sum of 3 quarters · filed 2020-03-02 | -$79.12M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | -$24.52M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$42.20M derived: sum of 2 quarters · filed 2020-03-02 | -$62.36M derived: sum of 3 quarters · filed 2020-03-02 | -$36.19M 10-K · filed 2020-03-02 |
| 2017-09-30 | -$17.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$37.84M derived: sum of 2 quarters · filed 2018-11-06 | -$11.67M 10-Q · filed 2018-11-06 | -$63.23M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | -$20.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $6.01M 10-Q · filed 2018-08-07 | -$45.55M derived: sum of 3 quarters · filed 2019-03-01 | -$46.78M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $26.17M 10-Q · filed 2018-05-07 | -$25.39M derived: sum of 2 quarters · filed 2019-03-01 | -$26.62M derived: sum of 3 quarters · filed 2019-03-01 | |
| 2016-12-31 | -$51.55M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$52.79M derived: sum of 2 quarters · filed 2019-03-01 | -$55.36M 10-K · filed 2019-03-01 | |
| 2016-09-30 | -$1.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$3.81M 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | -$2.57M 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | -$44.27M 8-K · filed 2018-09-18 |